Pediatric patients with tenosynovial giant cell tumor: real-world evidence from an observational registry
This study was an analysis of an observational patient registry and therefore was not registered as a clinical trial; no trial registration number is available. The study protocol was approved by Advarra (protocol reference number: Pro00077310). Patient enrollment for this analysis occurred from October 6, 2022, to November 26, 2024.
Authors
- Sara Rothschild (ORCID: https://orcid.org/0000-0001-6602-3924)
- Sydney Stern (ORCID: https://orcid.org/0000-0002-1479-605X)
- Patrick McKenzie (ORCID: https://orcid.org/0000-0002-8983-6060)
- Giacomo Giulio Baldi (ORCID: https://orcid.org/0000-0003-0798-7752)
- Thomas J. Scharschmidt
Institutions
- Nationwide Children's Hospital (US)
- Harvard University (US)
- University of Miami (US)
- Trellis Growing Systems (US)
- Sylvester Comprehensive Cancer Center (US)
- Life Raft Group (US)
- Hospital of Prato (IT)
Publication Details
- Journal
- Orphanet Journal of Rare Diseases
- Published
- 2026-01-30
- DOI
- https://doi.org/10.1186/s13023-026-04231-7
- Primary Topic
- Musculoskeletal synovial abnormalities and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00